NM_182961.4:c.14061G>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_182961.4(SYNE1):​c.14061G>C​(p.Leu4687Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0755 in 1,613,398 control chromosomes in the GnomAD database, including 7,834 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L4687L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.073 ( 839 hom., cov: 32)
Exomes 𝑓: 0.076 ( 6995 hom. )

Consequence

SYNE1
NM_182961.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.916

Publications

11 publications found
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
SYNE1 Gene-Disease associations (from GenCC):
  • autosomal recessive ataxia, Beauce type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • arthrogryposis multiplex congenita 3, myogenic type
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Emery-Dreifuss muscular dystrophy 4, autosomal dominant
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina
  • autosomal dominant Emery-Dreifuss muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive myogenic arthrogryposis multiplex congenita
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 6-152330624-C-G is Benign according to our data. Variant chr6-152330624-C-G is described in CliVar as Benign. Clinvar id is 130405.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152330624-C-G is described in CliVar as Benign. Clinvar id is 130405.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152330624-C-G is described in CliVar as Benign. Clinvar id is 130405.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152330624-C-G is described in CliVar as Benign. Clinvar id is 130405.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.916 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.417 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNE1NM_182961.4 linkc.14061G>C p.Leu4687Leu synonymous_variant Exon 78 of 146 ENST00000367255.10 NP_892006.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNE1ENST00000367255.10 linkc.14061G>C p.Leu4687Leu synonymous_variant Exon 78 of 146 1 NM_182961.4 ENSP00000356224.5 Q8NF91-1
SYNE1ENST00000423061.6 linkc.13848G>C p.Leu4616Leu synonymous_variant Exon 77 of 146 1 ENSP00000396024.1 A0A0C4DG40
SYNE1ENST00000490135.6 linkn.1407G>C non_coding_transcript_exon_variant Exon 2 of 11 1

Frequencies

GnomAD3 genomes
AF:
0.0735
AC:
11173
AN:
152112
Hom.:
836
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0398
Gnomad AMI
AF:
0.0625
Gnomad AMR
AF:
0.0795
Gnomad ASJ
AF:
0.0401
Gnomad EAS
AF:
0.431
Gnomad SAS
AF:
0.153
Gnomad FIN
AF:
0.0679
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0622
Gnomad OTH
AF:
0.0881
GnomAD2 exomes
AF:
0.0961
AC:
23947
AN:
249198
AF XY:
0.0970
show subpopulations
Gnomad AFR exome
AF:
0.0400
Gnomad AMR exome
AF:
0.0646
Gnomad ASJ exome
AF:
0.0476
Gnomad EAS exome
AF:
0.425
Gnomad FIN exome
AF:
0.0708
Gnomad NFE exome
AF:
0.0601
Gnomad OTH exome
AF:
0.0852
GnomAD4 exome
AF:
0.0757
AC:
110627
AN:
1461168
Hom.:
6995
Cov.:
33
AF XY:
0.0771
AC XY:
56059
AN XY:
726914
show subpopulations
African (AFR)
AF:
0.0377
AC:
1262
AN:
33480
American (AMR)
AF:
0.0649
AC:
2900
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0461
AC:
1206
AN:
26136
East Asian (EAS)
AF:
0.411
AC:
16300
AN:
39698
South Asian (SAS)
AF:
0.131
AC:
11268
AN:
86242
European-Finnish (FIN)
AF:
0.0713
AC:
3765
AN:
52774
Middle Eastern (MID)
AF:
0.0631
AC:
364
AN:
5768
European-Non Finnish (NFE)
AF:
0.0614
AC:
68262
AN:
1111968
Other (OTH)
AF:
0.0878
AC:
5300
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
6912
13824
20736
27648
34560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2776
5552
8328
11104
13880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0735
AC:
11186
AN:
152230
Hom.:
839
Cov.:
32
AF XY:
0.0769
AC XY:
5726
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.0399
AC:
1657
AN:
41560
American (AMR)
AF:
0.0796
AC:
1217
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0401
AC:
139
AN:
3468
East Asian (EAS)
AF:
0.431
AC:
2222
AN:
5150
South Asian (SAS)
AF:
0.153
AC:
740
AN:
4822
European-Finnish (FIN)
AF:
0.0679
AC:
720
AN:
10598
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.0622
AC:
4230
AN:
68020
Other (OTH)
AF:
0.0891
AC:
188
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
490
981
1471
1962
2452
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0614
Hom.:
120
Bravo
AF:
0.0729
Asia WGS
AF:
0.281
AC:
973
AN:
3478
EpiCase
AF:
0.0579
EpiControl
AF:
0.0616

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Jan 25, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Nov 28, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive ataxia, Beauce type Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
5.3
DANN
Benign
0.82
PhyloP100
0.92
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3734365; hg19: chr6-152651759; COSMIC: COSV54935068; COSMIC: COSV54935068; API